Back to User profile » Dr Kefei Dou
Papers published by Dr Kefei Dou:
Comparative Evaluation of Prolonged Dual Antiplatelet Therapy versus Conventional Regimens on Prognosis in Patients with High Residual Inflammatory Risk: Results from a Prospective Observational Study
Wang Z, Song Y, Zheng Z, Du Y, He J, Song C, Fu R, Dong Q, Song W, Yin D, Dou K
Journal of Inflammation Research 2026, 19:607214
Published Date: 25 June 2026
The Combined Effect of Platelet-to-HDL-Cholesterol Ratio and Glycemic Metabolism Status on the Prognosis of Patients Undergoing Percutaneous Coronary Intervention: A Large-Scale Retrospective Cohort Study
Yang Z, Li Z, Gao Y, Gao A, Li X, Wang Y, Dou K, Wang X, Guo T, Qiu H
Journal of Inflammation Research 2026, 19:544921
Published Date: 10 March 2026
Hs-CRP, Diabetic Status, and Adverse Events Among Patients Receiving Statin Therapy Following PCI—A Prospective Registry-Based Study
Chen X, Wang HY, Sun W, Lin Z, Qiao Z, Bian X, Yin D, Feng L, Zhu C, Song W, Wang H, Jia L, Dong Q, Dou K
Journal of Inflammation Research 2025, 18:9261-9274
Published Date: 15 July 2025
The Combined Effect of Systemic Immune-Inflammation Index and Type 2 Diabetes Mellitus on the Prognosis of Patients Undergoing Percutaneous Coronary Intervention: A Large-Scale Cohort Study
Bian X, He J, Zhang R, Yuan S, Dou K
Journal of Inflammation Research 2023, 16:6415-6429
Published Date: 27 December 2023
Discordance Between Neutrophil to Lymphocyte Ratio and High Sensitivity C-Reactive Protein to Predict Clinical Events in Patients with Stable Coronary Artery Disease: A Large-Scale Cohort Study
He J, Song C, Zhang R, Yuan S, Li J, Dou K
Journal of Inflammation Research 2023, 16:5439-5450
Published Date: 20 November 2023